| 摘要 |
Novel T129 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length T129 proteins, the invention further provides isolated T129 fusion proteins, antigenic peptides and anti-T129 antibodies. The invention also provides T129 nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a T129 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
|
